TITLE

Effects of High- vs Low-dose ARBs on Outcomes in Patients with CHF

AUTHOR(S)
Karpman, Harold L.
PUB. DATE
January 2010
SOURCE
Internal Medicine Alert;1/29/2010, Vol. 32 Issue 2, p13
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the effects of angiotensin-receptor blockers (ARBs) to treat patients with heart failure.
ACCESSION #
48186814

 

Related Articles

  • Valsartan Reduces Death and Morbidity in Heart Failure Patients. Neff, Matthew; Cohn, Jay N. // American Family Physician;5/15/2001, Vol. 63 Issue 10, p2024 

    Focuses on a study on the role of angiotensin II receptor blocker valsartan in reducing morbidity and death in heart failure patients. Methodology; Rate of discontinuation due to side effects.

  • New evidence for ARBs in heart failure. Saunders, Carol S. // Patient Care;1/30/2001, Vol. 35 Issue 2, p8 

    Presents the results of a study which assessed the efficacy of angiotensin II receptor blockers (ARB) in treating heart failure. Effects of valsartan; Indication of the results.

  • ACE inhibitors: Usual doses may be too low to lower morbidity, death. Leibovitch, Eric R. // Geriatrics;Mar97, Vol. 52 Issue 3, p76 

    Presents an abstract of the article `Do Angiotensin-Converting Enzyme Inhibitors Prolong Life in Patients with Heart Failure Treated in Clinical Practice?' by M. Packer published in the `Journal of the American College of Cardiology' dated 1996.

  • Severity of heart failure and dosage of angiotensin converting enzyme inhibitors. Clark, A.L.; Coats, A.J.S. // BMJ: British Medical Journal (International Edition);4/15/95, Vol. 310 Issue 6985, p973 

    Studies the uses of angiotensin converting enzyme inhibitors for chronic heart failure in a tertiary referral center. Investigation of the relation between the regimen used and patient variables and how this related to the dosages.

  • Stick with highest ACE inhibitor dose.  // Pulse;5/25/2011, Vol. 71 Issue 19, p9 

    The article offers information on the efficiency of low-dose angiotensin converting enzyme (ACE) inhibitors in heart failure with recommendations of titration and blood pressure monitoring.

  • Treating diastolic heart failure. Voors, Adriaan A.; De Jong, Richard M. // Heart;Aug2008, Vol. 94 Issue 8, p971 

    The article reflects on issues regarding the treatment of diastolic heart failure. It talks about the absence of evidence for a specific drug for the reduction of mortality and morbidity in patients with diastolic heart failure. A comparative study between angiotensin converting enzyme (ACE)...

  • RELATIONSHIP BETWEEN POLYMORPHISM OF ACE AND THE CURATIVE EFFECT OF METOPROLOL ON CHRONIC HEART FAILURE.  // Heart;Oct2010 Supplement, pA211 

    An abstract of the article "Relationship Between Polymorphism of ACE and the Curative Effective of Metoprolol on Chronic Heart Failure" by Miao Peizhi and Gu Shuiming is presented.

  • Therapeutic Role of Angiotensin II Receptor Blockers in the Treatment of Heart Failure. Monohar, Prerana; Pina, Ileana L. // Mayo Clinic Proceedings;Mar2003, Vol. 78 Issue 3, p334 

    Examines the effects of angiotensin II receptor blockers (ARB) on the treatment of heart failure. Renin-angiotensin system; Characteristics of ARB; Evaluation of Losartan in the elderly trial; Evaluation of strategies for left ventricular dysfunction.

  • AT1 Receptor Antagonists. Verheijen, I.; Vanderheyden, P. M. L.; De Backer, J. P.; Vauquelin, G. // Current Medicinal Chemistry - Cardiovascular & Hematological Age;Mar2004, Vol. 2 Issue 1, p69 

    Type 1 receptors (AT1) for the peptide hormone angiotensin II play a crucial role in the cardiovascular homeostasis. In this regard, several selective, orally active non-peptide antagonists have been developed for the treatment of hypertension and congestive heart failure. Pre-clinically, they...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics